Delaware | 94-3078125 | |
(State or other jurisdiction | (I.R.S. Employer | |
of incorporation or organization) | Identification No.) |
Proposed Maximum | Proposed Maximum | |||||||||||||
Title of Each Class of | Amount to be | Offering Price Per | Aggregate Offering | Amount of | ||||||||||
Securities to be Registered | Registered(1)(2) | Share(1) | Price(1) | Registration Fee | ||||||||||
Common Stock, $0.01 par value per share |
5,605,250 shares | $2.315(3) | $12,976,153 | $399.00 | ||||||||||
Common Stock, $0.01 par value per share |
25,000 shares(4) | $2.28 | $57,000 | $1.75 | ||||||||||
Common Stock, $0.01 par value per share |
3,369,750 shares(5) | $2.00 | $6,739,500 | $207.00 | ||||||||||
TOTALS |
9,000,000 | $19,772,653 | $607.75 | |||||||||||
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, this registration statement also covers such additional shares of Common Stock as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. | |
(2) | Represents (i) 6,000,000 shares of Common Stock authorized for issuance under the Amended and Restated 2006 Equity Incentive Plan of StemCells, Inc. (the 2006 Incentive Plan), less shares of common stock reserved for issuance pursuant to options previously granted under the 2006 Incentive Plan, plus (ii) up to an additional 3,000,000 shares of Common Stock that may be added pursuant to the evergreen provision contained in the 2006 Incentive Plan. The evergreen provision provides that on each January 1 (beginning January 1, 2008) an additional number of shares equal to 4% of then-outstanding shares of the Registrant will be added to the shares authorized for issuance under the 2006 Incentive Plan. | |
(3) | The offering price of $2.315 per share has been estimated solely for the purpose of determining the registration fee pursuant to Rule 457(c) and 457(h)(1) on the basis of the average high and low prices of the common stock, par value $0.01 per share, as reported on the Nasdaq Global Market on July 18, 2007. | |
(4) | Represents shares of Common Stock reserved for issuance upon the exercise of options previously granted under the 2006 Incentive Plan with an exercise price of $2.28 per share. | |
(5) | Represents shares of Common Stock reserved for issuance upon the exercise of options and stock appreciation rights with an exercise price of $2.00 per right previously granted under the 2006 Incentive Plan. |
(a) | The Registrants latest Annual Report on Form 10-K for the fiscal year ended December 31, 2006 filed with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the Exchange Act), on March 15, 2007. | ||
(b) | The Registrants Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 filed with the Commission pursuant to the Exchange Act on May 7, 2007. | ||
(c) | The Registrants Current Reports on Form 8-K filed with the Commission on January 12, 2007 and on May 7, 2007 (information reported under Item 5.03 only). | ||
(d) | The description of the common stock of the Registrant contained in the Registrants Registration Statement on Form 8-A (File No. 1-19871), including all amendments and reports filed for the purposes of updating such description. |
-2-
Exhibit | |||
4.1
|
Amended and Restated 2006 Equity Incentive Plan. | ||
5.1
|
Opinion of Ropes & Gray LLP. | ||
23.1
|
Consent of Grant Thornton LLP. | ||
23.3
|
Consent of Ropes & Gray LLP (included in the opinion filed as Exhibit 5.1). | ||
24.1
|
Power of Attorney (included on the signature page of this Registration Statement under the caption Power of Attorney). |
(a) | The undersigned Registrant hereby undertakes: |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: |
(i) | To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the Securities Act); | ||
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of a prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the Calculation of Registration Fee table in the effective registration statement; | ||
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; |
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) above shall not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement. |
-3-
(2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. | ||
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(b) | The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrants annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plans annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. | ||
(c) | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
-4-
StemCells, Inc. | ||||||
By: | /s/ Martin M. McGlynn | |||||
Name: Martin M. McGlynn Title: President and Chief Executive Officer |
Signature | Title | Date | ||
/s/ Martin M. McGlynn
|
President, Chief Executive Officer and Director | July 9, 2007 | ||
Martin M. McGlynn |
||||
/s/ Rodney K.B. Young
|
Chief Financial Officer (Principal Financial Officer) | July 11, 2007 | ||
Rodney K.B. Young |
||||
/s/ George Koshy
|
Chief Accounting Officer (Principal Accounting Officer) | July 11, 2007 | ||
George Koshy |
||||
/s/ John J. Schwartz, Ph.D
|
Chairman | July 6, 2007 | ||
John J. Schwartz, Ph.D |
||||
/s/ Eric H. Bjerkholt
|
Director | July 10, 2007 | ||
Eric H. Bjerkholt |
||||
/s/ Ricardo B. Levy, Ph.D
|
Director | July 8, 2007 | ||
Ricardo B. Levy, Ph.D |
||||
/s/ Roger M. Perlmutter M.D., Ph.D.
|
Director | July 10, 2007 | ||
Roger M. Perlmutter M.D., Ph.D. |
||||
/s/ Desmond H. OConnell, Jr.
|
Director | July 9, 2007 | ||
Desmond H. OConnell, Jr. |
||||
/s/ Irving L. Weissman, M.D.
|
Director | July 6, 2007 | ||
Irving L. Weissman, M.D. |
4.1
|
Amended and Restated 2006 Equity Incentive Plan | |
5.1
|
Opinion of Ropes & Gray LLP. | |
23.1
|
Consent of Grant Thornton LLP. | |
23.3
|
Consent of Ropes & Gray LLP (included in the opinion filed as Exhibit 5.1). | |
24.1
|
Power of Attorney (included on the signature page of this Registration Statement under the caption Power of Attorney). |